In honour of international Support Don’t Punish Day 2023, the NZ Drug Foundation is today releasing an evidence-backed plan to end overdose deaths in Aotearoa.
Given MDMA’s popularity, potential therapeutic uses, and low harm profile, is it time we re-examine how we regulate it here? Drug Foundation Senior Communications Advisor Feilidh Dwyer investigates.
Join the NZ Drug Foundation's Lived & Living Experience Forum: Pae Ora - Our Health. Connect, learn, & collaborate to improve hauora needs.
In Aotearoa, scientists, iwi, as well as hobbyists and amateurs are busy researching what psilocybin’s potential could be. So, what’s next for psilocybin in Aotearoa?
A hāpori (community) from Rangiwaho marae in Tairāwhiti Gisborne is embarking on a ground-breaking study that will explore using the indigenous Psilocybe weraroa fungus as a potential treatment for members of their community dealing with me
Our findings from our first full year as a licensed drug checking provider.
Russell Brown takes a look at how Australia's recent move to allow psilocybin and MDMA for prescription would work in practice, and whether a similar shift could be possible in New Zealand.
Drug checking services at Rhythm and Vines found potent psychedelic and stimulant, 25B-NBOH, sold as tabs of LSD.